The Global Sucralfate Market is anticipated to grow at a CAGR of 4.8% during the forecast period. Sucralfate is the generic form of the brand-name drug, Carafate. It is a prescription medicine used to treat ulcers of the upper gastrointestinal tract, peptic ulcer disease, and to prevent reoccurrence of ulcers. Sucralfate is a hydroxy aluminum salt of sucrose octasulfate that functions as a local mucosal adherent. It forms a coating over ulcers by sticking to the affected area, which protects the area from acid and enzymes and helps ulcers to heal more quickly.

Get Full Report Browser Click Here @ https://www.quincemarketinsights.com/industry-analysis/sucralfate-market/61559

Sucralfate is a hydroxy aluminum salt of sucrose octasulfate that functions as a local mucosal adherent. It forms a coating over ulcers by sticking to the affected area, which protects the area from acid and enzymes and helps ulcers to heal more quickly. Sucralfate can also be used in treating ulcers and upper gastrointestinal disorders of dog, horse, and cat, which may arise due to drugs (particularly non-steroidal anti-inflammatory drugs (NSAIDs) and corticosteroids), toxic chemical ingestion, liver disease, renal failure, carcinoma, stress (trauma, shock, sepsis, and burns), and inflammatory bowel disease.

The factors that propel the growth of the Sucralfate Market include increasing demand, rapid urbanization & industrialization, and product development & technological innovations. In addition, the key factors such as geriatric population, and increasing incidence of intestinal ulcers significantly fuel the market growth. On the other hand, there ae also factors that may hinder the market growth such as side effects like mild itching or skin rash; nausea, vomiting, upset stomach; headache; etc.

Companies Covered: Key players in the market are focused on acquisition and collaboration strategies to enhance their research and development activities, which in turn is expected to propel the market growth over the forecast period. The key leading players in the market include SRL Pharma, Nitika Chemicals., Teva Pharmaceutical Industries Ltd., Lisapharma S.p.A, Aptalis Pharma US, Inc., Uniprix Group, Rx Outreach, Abcam Plc, and Quimica Alkano.

Key Factors Impacting the Growth of Sucralfate Market:
• Increasing number of people affected by H. pylori infection is expected to increase the risk of gastric and duodenal ulcers, which in turn is expected to augment the growth of the U.S. sucralfate market.
• Growth in research and development activities is expected to drive the developed countries market growth.

Market Segmentation:
By Type
• Powder
• Suspension

By End Users
• Hospitals
• Laboratory
• Others

By Distribution Channel
• Offline stores
• Online Stores

By Region:
North America
Asia Pacific
Western Europe
Eastern Europe
Middle East
Rest of the World

Reasons to Buy This Report:
• Market size estimation of the sucralfate market on a regional and global basis
• Unique research Usage for market size estimation and forecast
• Profiling of major companies operating in the market with key developments
• Broad scope to cover all the possible segments helping every stakeholder in the market

ABOUT US:
QMI has the most comprehensive collection of market research products and services available on the web. We deliver reports from virtually all major publications and refresh our list regularly to provide you with immediate online access to the world’s most extensive and up-to-date archive of professional insights into global markets, companies, goods, and patterns.

Contact:
Quince Market Insights
Ajay D. (Knowledge Partner)
Office No- A109
Pune, Maharashtra 411028
Phone: US +1 208 405 2835 / UK +44 121 364 6144 / APAC +91 706 672 4848
Email: [email protected]
Web: www.quincemarketinsights.com